Dietary management is being hailed as an effective strategy for the management of irritable bowel syndrome. Specifically, a diet low in fermentable carbohydrates (FODMAPs) has demonstrated efficacy in approximately 70% of patients. As evidence in support of the low FODMAP diet continues to emerge, there is increasing debate regarding implementation of the diet particularly concerning who should educate patients and how to educate them. Registered dieticians have largely pioneered the evidence that supports the effectiveness of the low FODMAP diet in irritable bowel syndrome, and the diet is recognized as a dietician-led therapy. However, there is an increasing trend for nondietician-led implementation of the diet despite an absence of evidence on both the clinical or cost-effectiveness of such. Additionally, there is a growing requirement for dietetic services to increase capacity in response to increasing referrals, and consequently, there is a need to investigate innovative ways to educate patients whilst maintaining dieticianled intervention. Herein, we review the evidence for delivery of the low FODMAP diet and discuss potentially effective methods for service delivery.
The low FODMAP diet is quickly becoming the cornerstone for effective dietary management in irritable bowel syndrome (IBS) with an expanding evidence base to support the clinical efficacy of the diet. It involves dietary restriction of high FODMAP foods for a period of 4-8 weeks followed by systematic reintroduction of individual FODMAPs to tolerance. The therapeutic nature of the low FODMAP diet is based on symptom improvement rather than addressing the underlying pathological cascade; therefore, it is a symptom management strategy and not a cure for IBS. It is a complex dietary strategy, and clinical effectiveness of the low FODMAP diet has been demonstrated using dietitian-led counselling; however, in clinical practice, other less comprehensive and unsubstantiated educational methods are increasingly implemented.
Who should deliver the low FODMAP diet
Clinical guidelines recognize the importance of the low FODMAP diet in the management of IBS. 1, 2 The National Institute for Health and Clinical Excellence guidelines state that dietary management should "only be given by a healthcare professional with expertise in dietary management." Registered dietitians have extensive knowledge of food and nutrition in health and disease and are the leading experts in educating patients on disease-specific dietary management, including IBS. Furthermore, they are governed by an ethical code for evidence-based practice. Indeed, dietitians directly contribute to research elucidating the mechanistic basis and clinical efficacy of the low FODMAP diet. [3] [4] [5] [6] As described elsewhere in this series, the low FODMAP diet is a complex intervention, and the evidence base has predominantly arisen from dietitian-led low FODMAP advice. [3] [4] [5] [6] [7] [8] Non-dietitian-led implementation of the low FODMAP diet represents significant departure from the evidence base as well as recommendations from clinical guidelines.
There are an increasing number of robust randomized controlled trials (RCTs) 3, 5, 9, 10 and non-RCTs [6] [7] [8] 11, 12 that support the use of the low FODMAP diet in IBS, all of which have utilized dietitian-led education. A crossover feeding study demonstrating the mechanistic basis for the low FODMAP diet 13 and dietary FODMAP composition analyses have also been pioneered using dietitian-led education. 14, 15 In Australia, a dietitian-led randomized, crossover feeding study compared the low FODMAP diet to a typical Australia (control) diet in patients with IBS and healthy controls. 3 The authors reported lower overall gastrointestinal symptom scores on the low FODMAP compared with the control diet. Individual symptoms, notably bloating, pain, and flatulence, were all significantly reduced with the low FODMAP but not the control diet. Feeding studies are advantageous in that all food and beverages can be provided to participants. However, such studies lack a real-world perspective, as the provision of foods eaten as part of normal day-to-day living is unrealistic. Hence, it is difficult to confidently extrapolate these findings into clinical practice. Blinding and placebo response as well as participant deviation from protocol or misunderstanding of dietary advice are problematic for dietary intervention studies. The provision of a control or sham diet minimizes these limitations whereby the diet is manipulated in a similar way to that of the intervention without any consequences on nutritional intake or symptoms. Indeed, a recent RCT has compared a low FODMAP diet with a sham diet and provides further support for dietitian-led low FODMAP education. 16 More recently, dietitian-led delivery of the low FODMAP diet has been successfully used in retrospective 17 and prospective 18 studies in patients with inflammatory bowel disease and functional gastrointestinal symptoms reducing the frequency of abdominal pain, diarrhea, bloating, and flatulence. A randomized, double blind, and cross-over study in children with IBS compared a low FODMAP diet with a typical American diet (control) for 48 h 9 using dietitian-led education. Episodes of abdominal pain were significantly less frequent on the low FODMAP diet compared with the typical American diet. It is these collective dietitian-led low FODMAP studies that have been critically reviewed and are the basis of recommendations in guidelines. Table 1 provides an overview of the evidence for the low FODMAP diet according to who led the teaching of the diet.
There are two studies that have used nurse-led dietary counselling for IBS with varying symptom response. One study reported improved symptom response following three consultations on dietary management including a FODMAP-restricted diet. 19 However, the degree of symptom improvement reported is difficult to interpret because of the variability of measurement tools used in this study compared with other studies. In a second study, the authors failed to find any significant difference in overall symptom response between patients who did or did not receive nurse-led education on the low FODMAP diet; although abdominal pain was significantly reduced in those receiving nurse-led education. 20 There is an increasing awareness of the low FODMAP diet, and health professionals with no formal training in clinical nutrition are increasingly advising on the diet. One survey reports that 79% of doctors provide lifestyle or dietary advice to IBS patients with little evidence of dietetic involvement, 21 and whilst no published data exist for the UK, ongoing discussions with doctors indicate that they frequently provide patients with basic information on the low FODMAP diet (for example, one-page leaflet or direction to self-research the diet online) without referral for dietitian-led education. Albeit dietary treatments pose less risk than pharmacological strategies, self-implementation of the diet is not an evidence-based method for self-management, nor is it supported by national guidelines. 2 In fact, it represents deviation from best practice. 2 There are an increasing number of websites, blogs, and "internet gurus" proclaiming to assist patients with the low FODMAP diet, yet the quality of information available on such sites is indeed questionable and often incomplete or incorrect. Whilst reputable sources of information are available online, it can be assumed that patients and potentially health professionals alike may lack the discriminatory acuity to determine reputable versus non-reputable sources. Social media is a powerful tool and can, when used appropriately, be of benefit in management of chronic conditions. However, it cannot replace the input of a qualified and evidence-based dietitian for dietary management of IBS, particularly given that a trusting patient and health professional relationship is the cornerstone of IBS clinical management. 22 Additionally, there are no data describing the efficacy, clinical consequences, or cost-effectiveness of the provision of basic information on the low FODMAP diet, and oftentimes, the dietary information provided is outdated or incomplete. Nondietitian-led implementation of the diet is troublesome, particularly as patients often select aspects of a diet that appeal Low FODMAP diet; educationto them and discount other elements of the diet. It also represents significant inequality of care. Nutritional concerns regarding the low FODMAP diet are noted in the literature 6 and are another reason to be concerned regarding non-dietitian-led implementation of the diet. Additionally, it is questionable whether unguided implementation of the diet is correctly undertaken or whether proper food reintroduction is completed, and it may be that nutritional inadequacies arise because of inappropriate dietary over-restriction. This may be especially problematic in specific populations such as individuals with inflammatory bowel disease plus concomitant functional gastrointestinal symptoms or women of childbearing age. There is also a less well-recognized trend for the development of obsessive disorders with overly restricted eating patterns (for example, orthorexia nervosa) amongst patients on the low FODMAP diet, and the complexity and stringency of this diet may encourage obsessive dietary patterns. These concerns further support the necessity of dietetic input. Additionally, researchers as well as recommendations from gastroenterologists continue to stress the importance of dietitian-led education and caution against non-dietitian-led approaches. 22 
How to deliver the low FODMAP diet
The success of the low FODMAP diet has largely been achieved through the integration of the diet into traditional dietitian-led service delivery models, predominantly in the form of one-to-one consultations. Whilst the duration and number of appointments that patients receive vary between institutions, detailed education on the diet and comprehensive symptom assessment is imperative.
IBS referrals now represent 50% of all gastroenterology diagnoses, 23 and, with a prevalence rate of up to 11% globally (range 7-21%), the increasing influx of patients requiring low FODMAP advice is inundating dietetic capacity. Group education has been used with much success in dietary counselling for other chronic conditions, and its adoption for dietary counselling in IBS is promising. 8 A recent UK study compared the clinical and costeffectiveness of a novel group pathway compared with a traditional one-to-one dietitian-led service for low FODMAP dietary counselling in IBS. Patients referred for low FODMAP education were pre-screened in a telephone clinic. Medical history, symptoms, and dietary intake as well as suitability for group education were reviewed; patient preference was also considered. Those suitable for group education received an initial appointment consisting of up to 12 patients per group. Symptom evaluation, education on physiological framework for, and comprehensive information on the low FODMAP diet were provided in a group setting. Dietary resources including booklets on suitable and unsuitable foods, basic recipes, food product packaging, meal planning, and strategies for eating outside the home were provided to complement the session. A follow-up appointment was scheduled for at least 6 weeks later and was delivered using the same educational approach as the initial appointment (group or one to one). Patients unsuitable for or who declined group education were seen in a traditional one-toone consultation. A similar format, content, and supplementary literature was provided. The clinical effectiveness of the group education was compared with the one-to-one education. There was no difference in clinical effectiveness between both the group and one-to-one education as assessed using a global symptom question (54% vs 61%, p = 0.71), and there was a significant decrease in individual symptom severity from baseline in both educational arms. Stool consistency and frequency improved regardless of the educational model used.
Whilst no differences were observed in clinical effectiveness between educational approaches, the group pathway was costed using a decision model. For the cost analysis, the group pathway (telephone clinic, group, and capacity for one-to-one education as described previously) was compared with a hypothetical traditional one-to-one pathway to act as a control. The outcomes of the one-to-one arm of the group pathway were considered comparable with the outcomes from a traditional one-to-one pathway. Theoretical costs were calculated per patient for a oneto-one appointment.
The total cost for the group pathway was £31,713.36 (total of 364 patients), whereas the hypothetical cost for the one-to-one pathway for the same number of patients was £44,149.38 On a per patient basis, group education was approximately 50% less expensive (£67.19 vs £139.20 group vs one-to-one, respectively; Fig. 1 ). The total cost per quality-adjusted life-year gained for the group pathway was £3052.36. Overall, the group pathway was a more cost-effective model of service delivery but demonstrated equal clinical effectiveness. It was also acceptable to patients. However, the study was limited in that it was a prospective observational service evaluation that lacks the rigor Figure 1 Graphical representation of novel group pathway compared with traditional one-to-one pathway. Costs per patient for the traditional pathway are modeled on theoretical costs as described by Whigham et al. 8 of an RCT and the absence of a true control group limited the cost analysis. Despite this, the preliminary data suggest there is a need for future prospective, adequately powered RCTs to further evaluate the clinical and cost-effectiveness of group education pathways for the dietary management of IBS.
Conclusion
Dietitian-led implementation of the low FODMAP diet is an effective strategy for the management of IBS, yet there is a need for further research, particularly on the long-term impact of the diet. The evidence base supports the use of dietitian-led education, in both one-to-one and group service delivery models. Group education demands further evaluation for the dietary management of IBS as preliminary evidence suggests it is a clinically effective and economic model of service delivery. The trend for non-dietitian-led implementation of the diet is of concern particularly as there is no evidence on the clinical effectiveness or risks associated with such practices and the importance of dietitian-led management in IBS needs increased recognition in clinical practice. Dietitians are the only qualified health professionals who assess, diagnose, and treat dietary and nutritional problems and are required to deliver evidence-based therapy. Furthermore, dietitians are governed by an ethical code of practice and continue to generate instrumental research data in the evolving area of the dietary management of IBS.
